全氟丁烷增强超声诊断胸膜下肺病变的准确性
单中心回顾性研究纳入2022年1月至2023年3月连续70例胸膜下肺病变患者,用全氟丁烷增强超声观察0-180秒及3、5、10分钟洗脱,评估鉴别良恶性的诊断价值。峰值强度、到达时间和10分钟洗脱在良恶性间有显著差异,三者联合的AUC为0.897(95%CI 0.806-0.988),高于单一指标。
要点
- 全氟丁烷增强超声可用于鉴别胸膜下肺病变的良恶性。
- 10分钟洗脱的敏感度和准确度显著高于到达时间(均p<0.05)。
- 到达时间、峰值强度与10分钟洗脱联合诊断AUC为0.897(95%CI 0.806-0.988),优于单一指标。
核心结论
- 全氟丁烷增强超声可鉴别肺病变的良恶性,到达时间、峰值强度与10分钟洗脱联合诊断优于单一特征。
研究设计与样本
- 单中心回顾性研究,连续纳入2022年1月至2023年3月胸膜下肺病变患者70例(良性17例,恶性53例),以活检和随访检查确认病因,采用全氟丁烷增强超声连续观察0-180秒及3、5、10分钟洗脱。
关键影像表现/征象
- 峰值强度、到达时间和10分钟洗脱在恶性与良性病变间有显著差异。
- 10分钟洗脱的敏感度和准确度显著高于到达时间(均p<0.05)。
诊断标准与关键数值
- 到达时间、峰值强度与10分钟洗脱联合诊断恶性肺病变的AUC为0.897(95%CI 0.806-0.988),显著高于到达时间或峰值强度单独诊断。
临床应用与阅片要点
- 观察胸膜下肺病变的全氟丁烷增强超声时,应记录到达时间、峰值强度和10分钟洗脱特征。
- 联合到达时间、峰值强度和10分钟洗脱进行诊断,其性能优于单一特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To investigate the diagnostic value of perfluorobutane-enhanced ultrasound (US) examinations for differentiating benign from malignant subpleural lung lesions.
METHODS: This single-center, retrospective study enrolled consecutive patients with subpleural lung lesions between January 2022 and March 2023. The cause of the lung lesions was confirmed by biopsy and follow-up examinations. The lesions were continuously evaluated using perfluorobutane-enhanced US for 0-180 s, and washout (WT) was observed after 3, 5, and 10 min. Univariate and multivariate analyses were used to identify significant US features, which were evaluated for their diagnostic performance. The diagnostic performance of combining several features for predicting malignant lung lesions was also assessed by multivariate logistic regression analysis.
RESULTS: Seventy cases were included (17 benign lesions [13 men, 4 women; mean age: 57.5 ± 12.2 years] and 53 malignant lesions [41 men, 12 women; mean age: 63.3 ± 11.6 years]). Peak intensity (PI), arrival time (AT), and WT after 10 min significantly differed between malignant and benign lesions. The sensitivity and accuracy were significantly higher for 10-minute WT than for AT (both p < 0.05). The area under the curve of the combined diagnostic evaluation with AT, PI, and 10-minute WT was 0.897 (95% [CI]: 0.806-0.988), which was significantly higher than that of AT or PI alone.
CONCLUSION: Perfluorobutane-enhanced US can differentiate benign from malignant lung lesions, and combining AT, PI, and 10-minute WT for diagnostic purposes performed better than a single feature.
引用
- Chen W, Tang Q, Liang G, et al. Accuracy of Contrast-enhanced Ultrasonography with Perfluorobutane for Diagnosing Subpleural Lung Lesions. Acad Radiol. 2024. PMID: 39490320. doi:10.1016/j.acra.2024.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。